Clobetasol Propionateemollient Formulation Uses, Dosage, Side Effects and more
Clobetasol Propionateemollient Formulation is under investigation for the treatment of Scleroderma. Clobetasol Propionateemollient Formulation has been investigated for the prevention of Psoriasis and Cutaneous Atrophy Due to Corticosteroids.
| Trade Name | Clobetasol Propionateemollient Formulation |
| Availability | Prescription only |
| Generic | Clobetasol |
| Clobetasol Other Names | Clobetasol |
| Related Drugs | Humira, Cosentyx, Dupixent, prednisone, doxycycline, methotrexate, betamethasone topical, Remicade, Stelara, cyclosporine |
| Type | |
| Formula | C22H28ClFO4 |
| Weight | Average: 410.907 Monoisotopic: 410.166015296 |
| Groups | Approved, Experimental, Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | USA |
| Last Updated: | January 7, 2025 at 1:49 am |
Disease Interaction
Moderate: diabetes, diaper rash, hyperadrenocorticism, infections, ocular toxicities
